CNPD Research News: February 2023

CNPD Accomplishments

Congratulations to Kimberly Lucas! She was one of 147 masters and doctoral poster presenters who took part in the UND School of Graduate Studies Research Achievement Day!

Her poster took FIRST PLACE in the category of Professional, Social Sciences, Humanities, and Arts. Her work focused on the role of Vitamin D in treating diabetic foot ulcers.

Kimberly is enrolled in the M.S. in Nutrition program and her advisor is Dr. Desiree Tande (also pictured).

Congratulations to Kimberly and ALL who took part in an amazing day of presentations!

Upcoming Events

CNPD Research and Scholarship Day is April 28, 2023
10 a.m. – 1p.m. | Memorial Union Ballroom

We want you!

CNPD students are encouraged to participate in a day celebrating research, collaboration, scholarship, and creative activities.

Eligible Participants

CNPD students from Nursing, Nutrition & Dietetics and Social Work who are engaged in research, scholarship and creative work through theses, dissertations, non-thesis projects, and independent studies, or who have conducted substantial research as a part of coursework.

Students may either present solo research as part of a poster presentation, or if research was done collaboratively, they may present with other co-presenters.

Opportunities are available for both on-campus and online/distance learning students.

Deadlines

• The final deadline to submit a poster presentation title to participate in CNPD Research & Scholarship Day is Sunday, March 5^th by 11:59 p.m.
• Posters must be submitted to the print center via the website instructions by Thursday, April 13^th at 11:59 p.m. The College of Nursing and Professional Disciplines will pay the cost of one (1) poster printing.

Students can learn more about the event, presentation information, and more by visiting the event page.

Funding Opportunities

Sent on behalf of the UND VPR.

Please see the attached funding opportunity announcements.

Announcement of Combat Casualty Care Program

• This RPP is focused on developing a multi-institutional, interdisciplinary network of universities, companies, military laboratories, and investigators designed to promote a seamless integration of development, from research through translational and clinical research, as the best means of bringing regenerative medicine therapies to practice.
• The goal of this program is to accelerate the development of regenerative medicine prototypes to restore function to and heal injured Warfighters using this collaborative network, or consortium. The intent of the RPP is to make a single award to a Coordinating Site that can leverage the combined expertise of the DoD, industry, and academia to advance regenerative medicine prototypes to the clinic. For more details, please visit https://www.mtec-sc.org/solicitations/.

Announcement of Amyotrophic Lateral Sclerosis Research Program

• Pilot Clinical Trial Award
• Therapeutic Development Award
• Clinical Biomarker Development Award
• Therapeutic Idea Award

Announcement of Breast Cancer Research Program

• Transformative Breast Cancer Consortium Award
• Transformative Breast Cancer Consortium Development Award
• Clinical Research Extension Award
• Breakthrough Award Levels 1 and 2
• Breakthrough Award Level 3
• Breakthrough Award Level 4
• Era of Hope Scholar Award
• Innovator Award

Announcement of Epilepsy Research Program

• Leveraging Research Award
• Virtual Post-Traumatic Epilepsy Research Center (P-TERC) – Faculty Award
• Idea Development Award
• Research Partnership Award

Announcement of Peer Reviewed Medical Research Program

• Clinical Trail Award
• Discovery Award
• Focused Program Award
• Investigator-Initiated research Award
• Lifestyle and behavioral Health Interventions Research Award
• Technology/Therapeutic Development Award

Announcement of Combat Readiness-Medical research Program (CRRP)

• Translational Research Award
• At https://cdmrp.health.mil/pubs/press/2023/23crrppreann

Announcement of Tick-Bourne Disease Research Program (TBDRP)

• Idea Development Award
• Therapeutic/Diagnostic Research Award
• At https://cdmrp.health.mil/pubs/press/2023/23tbdrppreann

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https:eBRAP.org prior to the pre-application deadline. All applications must conform to the final Funding Opportunities/Program Announcements and General Application Instructions which can be found on the Grants.gov website (https://Grants.gov). A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Announcement of Registration and Call for Abstracts for May 16-17,2023, NIDA Genetics and Epigenetics Meeting, Natcher Conference Center, NIH, Bethesda MD

• You are invited to register and/or submit an abstract for the NIDA Genetics and Epigenetics Meeting to be held at Natcher Conference Center, Bldg. 45, on the NIH Campus in Bethesda MD. This is an in-person meeting.
• To register: https://apps1.seiservices.com/NIDA/GeneticsConsortium/Default.aspx
• To submit an abstract: https://apps1.seiservices.com/NIDA/GeneticsConsortium/docs/2023-AbstractForms_508c.pdf Abstracts are due by Midnight PST on March 3,2023
• There is no registration fee to attend this meeting. However, attendees are responsible for their own travel, meals, and lodging.

The goals of the meeting are to:

• Showcase the exciting research on the genetics and epigenetics of substance use disorders.
• Encourage collaboration among investigators with different expertise in genetics and epigenetics.
• Foster collaboration between investigators working on the genetics and epigenetics of substance abuse disorders and HIV/AIDS investigators.
• Identify new research opportunities in the genetics and epigenetics of substance use disorders.
• Provide attendees with an opportunity to meet with NIDA program directors to discuss their ideas for grant applications and funding opportunities.

Announcement of Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain (NOT-DA-20-039)

• The purpose of the Notice is to encourage investigators to submit grant applications to the National Institute on Drug Abuse (NIDA) to study the effects of cannabis and cannabinoid exposure on the developing brain, from pre-, peri-, and post-natal development through young adulthood in humans and using animal models.
• Application due dates: Standard dates apply by 5:00 PM local time of applicant organization.

Announcement of Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) (RFA-DA-23-056)

• This Funding Opportunity Announcement (FOA) will support transformative research to identify and validate mechanisms, signaling pathways, and therapeutic targets, for understanding and reversing the effects of an overdose and the observed toxicities caused by acute Ultra-Potent Synthetic (UPS) opioid exposure. This FOA will also support mechanistic studies of persistent or delayed pathophysiological effects be acute exposure to UPS opioids.
• Application Due Date (New and Renewal/Resubmission/Revision): November 17,2023, and November 19, 2024
• Link to the RFA: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-056.html

Announcement of Notice of Intent to Publish a Funding Opportunity Announcement for NIH Brain Development Cohorts Biospecimen Access (X01 Clinical Trial Not Allowed) (NOT-DA-22-064)

• The National Institute on Drug Abuse intends to promote a new resource access program by publishing a Funding Opportunity Announcement (FOA) to seek applications for the following: NIH Brain Development Cohorts (NBDC) Biospecimen Access Program (X01- Clinical Trial Not Allowed). This FOA will allow investigators to apply for access to biological samples from the Adolescent Brain Cognitive Development (ABCD) Study. By making these specimens available to the greater scientific community, this resource award seeks to maximize the scientific potential of the biospecimens collected in the ABCD Study and expand the scope of ABCD’s open science model, allowing scientists from around the world to utilize these specimens and enrich the child and adolescent health data being obtained from the ABCD Study.
• No funds will be provided through this opportunity. Applicants will be responsible for costs associated with conducting the research and sample shipment. Applicants will need to submit proof of funding for costs of analyses and sample shipment at the time of application.
• This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
• The FOA is expected to be published in Spring 2023 with an expected application due date in Summer 2023.
• This FOA will utilize the X01 activity code. See notice for more details of planned FOA.

 Announcement of Education Activities for Responsible of Complex, Large-Scale Data (R25-Clinical Trial Not Allowed) (RFA-DA-24-027)

• This FOA will support creative educational activities with a primary focus on methodological rigor in the analysis of large complex datasets involving brain, behavior, genomic, and socioenvironmental data. This could involve:
  • Courses for skills Development: For example. Advanced statistics and research design courses in a specific discipline or research area, rigor and robustness in research practice, or ethical conduct of biomedical research.
  • Curriculum or Methods Development: For example, to improve biomedical, behavioral or clinical science education, or develop novel instructional approaches or computer-based educational tools that support methodological rigor in analysis of large complex datasets.

Objectives:

• This Funding Opportunity Announcement (FOA) encourages applications that seek to advance methodological rigor in biomedical and behavioral research by supporting training on the responsible analyses of complex, large-scale datasets involving brain, behavioral, genomic, and socioenvironmental data.

Topics of interest include, but are not limited to:

• • Analytical approaches for large-scale, longitudinal data
    • Enhanced rigor and robustness in research practice (e.g., pre-registration of experimental protocols, plans, and analyses)
    • Estimation of meaningful associations, including population inferences, effect sizes, control of covariates, and interpretation of associations
    • Ethical conduct of biomedical and behavioral research, including consideration of social constructs such as race/ethnicity and gender, and the potential for stigmatization
    • Community-partnered research to inform data analyses and interpretation
    • Consideration of socioenvironmental contexts known to introduce inequities, such as family income and education, employment, housing, neighborhood-level characteristics, and exposure to violence
    • Factors to consider when examining the influence of socioenvironmental factors (e.g., non-random data missingness, sampling methodologies)
  • In addition, NIDA emphasizes responsible analyses of data related to neurodevelopment and neurocognition, as it relates to the substance use trajectory.
  • Research education programs may complement ongoing research training and education occurring at the applicant institution, but the proposed educational experiences must be distinct from those training and education programs currently receiving Federal support. R25 programs may augment institutional research training programs (e.g.., T32, T90) but cannot be used to replace or circumvent Ruth L. Kirschstein National Research Service Award (NRSA) programs.
  • Application Deadline: February 8,2024, 5:00 PM local time of applicant organization.